Literature DB >> 16639005

Otago glaucoma surgery outcome study: cytology and immunohistochemical staining of bleb capsules around Molteno implants.

Anthony C B Molteno1, Antony J Suter, Mark Fenwick, Tui H Bevin, Alex G Dempster.   

Abstract

PURPOSE: To describe the cytology and immunohistochemistry of Molteno implant capsules from cases of primary and secondary glaucoma.
METHODS: Histologic features of capsules including cell cytology, the distribution of activated (proliferating) cells, apoptosing cells, and membrane bound vesicles (presumed death messengers) were assessed by light microscopy and correlated with clinicopathological features in 10 noninflamed eyes with good intraocular pressure control (nine autopsy and one enucleation) obtained from 2 months to 16.8 years after insertion of Molteno implants.
RESULTS: All bleb capsules demonstrated two distinct layers. The thin external layer was cellular with fairly numerous small blood vessels coursing through normally staining, regularly arranged collagen fibers. The thicker, deeper layer was avascular, relatively acellular, and characterized by regularly arranged swollen and fragmented collagen fibers. Most cells in the external layer appeared normal; however, between 5% (in recently formed blebs) and approximately 50% (in well established blebs) showed cytological and/or immunohistochemical changes characteristic of metabolic activation and/or apoptosis. All cells in the deeper layer, regardless of time after surgery, also demonstrated cytological and/or immunohistochemical staining characteristic of metabolic activation and/or apoptosis. In addition, the deeper layer evidenced large numbers of minute membrane-bound vesicles (presumed death messengers).
CONCLUSIONS: The balance between activation and apoptosis regulates the thickness and permeability of bleb capsules, and the normal lifecycle of bleb capsules includes continual inner surface degeneration and external surface renewal.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16639005     DOI: 10.1167/iovs.05-0988

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  6 in total

1.  Absence of lymphatic vessels in non-functioning bleb capsules of glaucoma drainage devices.

Authors:  Robert Siggel; Falk Schroedl; Thomas Dietlein; Konrad R Koch; Christian Platzl; Alexandra Kaser-Eichberger; Claus Cursiefen; Ludwig M Heindl
Journal:  Histol Histopathol       Date:  2020-12-31       Impact factor: 2.303

2.  Altered expression of fibrosis genes in capsules of failed Ahmed glaucoma valve implants.

Authors:  Alka Mahale; Maha W Othman; Sami Al Shahwan; Ibrahim Al Jadaan; Ohood Owaydha; Zahid Khan; Deepak P Edward
Journal:  PLoS One       Date:  2015-04-16       Impact factor: 3.240

3.  Histopathologic and immunohistochemical features of capsular tissue around failed Ahmed glaucoma valves.

Authors:  Alka Mahale; Fatma Fikri; Khitam Al Hati; Sami Al Shahwan; Ibrahim Al Jadaan; Hind Al Katan; Rajiv Khandekar; Azza Maktabi; Deepak P Edward
Journal:  PLoS One       Date:  2017-11-09       Impact factor: 3.240

4.  Risk Factors for Failure in Double-Plate Tube Surgery for Refractory Glaucoma: 25 Years Surgical Experience.

Authors:  Susana Duch; Carlos A Arciniegas-Perasso; Stefania Piludu; Shirin Djavanmardi; Elena Milla
Journal:  Clin Ophthalmol       Date:  2021-02-09

5.  Comparison of Outcomes Following Glaucoma Drainage Tube Surgery Between Primary and Secondary Glaucomas, and Between Phakic and Pseudophakic eyes.

Authors:  Emily F Dawson; Brady E Culpepper; Charlotte A Bolch; Phuong T Nguyen; Alissa M Meyer; Cooper D Rodgers; Mary Kate Wilson; Ryan J Smith; Nicole C Rosenberg; C Richard Blake; Mark B Sherwood
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2021-11-24

Review 6.  Magnetic Resonance Imaging Study on Blebs Morphology of Ahmed Valves.

Authors:  Joana Ferreira; Fernando Fernandes; Madalena Patricio; Ana Brás; Cristina Rios; Ingeborg Stalmans; Luis Abegão Pinto
Journal:  J Curr Glaucoma Pract       Date:  2015-01-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.